Noam Goldway

792 total citations
23 papers, 489 citations indexed

About

Noam Goldway is a scholar working on Cognitive Neuroscience, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Noam Goldway has authored 23 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cognitive Neuroscience, 5 papers in Pharmacology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Noam Goldway's work include Functional Brain Connectivity Studies (5 papers), Cannabis and Cannabinoid Research (4 papers) and Psychedelics and Drug Studies (4 papers). Noam Goldway is often cited by papers focused on Functional Brain Connectivity Studies (5 papers), Cannabis and Cannabinoid Research (4 papers) and Psychedelics and Drug Studies (4 papers). Noam Goldway collaborates with scholars based in Israel, United States and United Kingdom. Noam Goldway's co-authors include Talma Hendler, Christian Paret, Haggai Sharon, Kathrin Cohen Kadosh, David E.J. Linden, Avihay Cohen, Silviu Brill, Catharina Zich, Eti Ben Simon and Marc Cavazza and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and NeuroImage.

In The Last Decade

Noam Goldway

23 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noam Goldway Israel 10 291 112 87 80 72 23 489
Nathan Hager United States 12 189 0.6× 111 1.0× 81 0.9× 37 0.5× 62 0.9× 31 411
Bailey Holt-Gosselin United States 10 312 1.1× 250 2.2× 113 1.3× 78 1.0× 70 1.0× 20 557
Zoe Samara United States 7 220 0.8× 168 1.5× 84 1.0× 52 0.7× 35 0.5× 8 378
Monique A. Pimontel United States 10 230 0.8× 194 1.7× 80 0.9× 201 2.5× 149 2.1× 13 580
Brooke R. Staveland United States 5 252 0.9× 184 1.6× 64 0.7× 59 0.7× 70 1.0× 7 401
Alexander Otti Germany 10 183 0.6× 53 0.5× 57 0.7× 121 1.5× 50 0.7× 13 346
Sarah M. Szymkowicz United States 14 276 0.9× 136 1.2× 50 0.6× 179 2.2× 112 1.6× 39 612
Ding Xu China 14 232 0.8× 81 0.7× 82 0.9× 70 0.9× 30 0.4× 37 511
Rebecca Johnson United Kingdom 4 149 0.5× 154 1.4× 67 0.8× 132 1.6× 103 1.4× 6 406
Yangqian Shen United States 6 328 1.1× 256 2.3× 121 1.4× 69 0.9× 35 0.5× 9 507

Countries citing papers authored by Noam Goldway

Since Specialization
Citations

This map shows the geographic impact of Noam Goldway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam Goldway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam Goldway more than expected).

Fields of papers citing papers by Noam Goldway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam Goldway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam Goldway. The network helps show where Noam Goldway may publish in the future.

Co-authorship network of co-authors of Noam Goldway

This figure shows the co-authorship network connecting the top 25 collaborators of Noam Goldway. A scholar is included among the top collaborators of Noam Goldway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noam Goldway. Noam Goldway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ching, Terence H. W., Noam Goldway, Natalie Gukasyan, et al.. (2024). Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors. International Review of Psychiatry. 36(8). 902–907. 1 indexed citations
2.
Jackson, Eric S., et al.. (2024). Stutterers’ experiences on classic psychedelics: A preliminary self-report study. Journal of Fluency Disorders. 81. 106062–106062. 3 indexed citations
3.
Goldway, Noam, et al.. (2024). Adolescents flexibly adapt action selection based on controllability inferences. Learning & Memory. 31(3). a053901–a053901. 1 indexed citations
4.
Tene, Oren, Liat Helpman, Anat Halevy, et al.. (2023). Limbic self‐neuromodulation as a novel treatment option for emotional dysregulation in premenstrual dysphoric disorder (PMDD); a proof‐of‐concept study. Psychiatry and Clinical Neurosciences. 77(10). 550–558. 1 indexed citations
5.
Goldway, Noam, Eran Eldar, Gal Shoval, & Catherine A. Hartley. (2023). Computational Mechanisms of Addiction and Anxiety: A Developmental Perspective. Biological Psychiatry. 93(8). 739–750. 7 indexed citations
6.
O’Donnell, Kelley C., Terence H. W. Ching, G Glick, et al.. (2023). What Is in a Name? The Many Meanings of “Psychedelic”. PubMed. 1(4). 187–189. 5 indexed citations
7.
Goldway, Noam, Nathan M. Petro, Jacob N. Ablin, et al.. (2022). Abnormal Visual Evoked Responses to Emotional Cues Correspond to Diagnosis and Disease Severity in Fibromyalgia. Frontiers in Behavioral Neuroscience. 16. 852133–852133. 3 indexed citations
8.
Goldway, Noam, Jackob N. Keynan, Lydia Hellrung, et al.. (2022). Feasibility and utility of amygdala neurofeedback. Neuroscience & Biobehavioral Reviews. 138. 104694–104694. 18 indexed citations
9.
Berger, Assaf, Ben Shofty, Noam Goldway, et al.. (2022). Lesions to both somatic and affective pain pathways lead to decreased salience network connectivity. Brain. 146(5). 2153–2162. 13 indexed citations
10.
Waissengrin, Barliz, et al.. (2020). Knowledge, attitude and practices regarding the use of medical cannabis: A national survey among Israeli oncologists.. Journal of Clinical Oncology. 38(15_suppl). e24125–e24125. 3 indexed citations
11.
Goldway, Noam, Christian Paret, Neomi Singer, et al.. (2019). Publisher Correction: Process-based framework for precise neuromodulation. Nature Human Behaviour. 3(5). 537–537. 1 indexed citations
12.
Goldway, Noam, Christian Paret, Neomi Singer, et al.. (2019). Process-based framework for precise neuromodulation. Nature Human Behaviour. 3(5). 436–445. 63 indexed citations
13.
Paret, Christian, Noam Goldway, Catharina Zich, et al.. (2019). Current progress in real-time functional magnetic resonance-based neurofeedback: Methodological challenges and achievements. NeuroImage. 202. 116107–116107. 80 indexed citations
14.
Goldway, Noam, Christian Paret, Neomi Singer, et al.. (2019). Publisher Correction: Process-based framework for precise neuromodulation. Nature Human Behaviour. 3(7). 760–760. 3 indexed citations
15.
16.
Waissengrin, Barliz, et al.. (2019). Use of medical cannabis: perceptions of Israeli oncologists. The Lancet Oncology. 20(4). 475–477. 19 indexed citations
17.
Sharon, Haggai, Noam Goldway, Itay Goor‐Aryeh, Elon Eisenberg, & Silviu Brill. (2018). Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain. Journal of Pain Research. Volume 11. 1411–1419. 26 indexed citations
18.
Goldway, Noam, Jacob N. Ablin, Marc Cavazza, et al.. (2018). Volitional limbic neuromodulation exerts a beneficial clinical effect on Fibromyalgia. NeuroImage. 186. 758–770. 43 indexed citations
19.
Goldway, Noam, et al.. (2016). EEG-Neurofeedback targeting amygdala activity reduces disease impact and improves sleep in Patients with Fibromyalgia. Frontiers in Human Neuroscience. 10. 1 indexed citations
20.
Simon, Eti Ben, Noga Oren, Haggai Sharon, et al.. (2015). Losing Neutrality: The Neural Basis of Impaired Emotional Control without Sleep. Journal of Neuroscience. 35(38). 13194–13205. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Hager Breakdown of academic impact, for papers by Bailey Holt-Gosselin Breakdown of academic impact, for papers by Zoe Samara Breakdown of academic impact, for papers by Monique A. Pimontel Breakdown of academic impact, for papers by Brooke R. Staveland Breakdown of academic impact, for papers by Alexander Otti Breakdown of academic impact, for papers by Sarah M. Szymkowicz Breakdown of academic impact, for papers by Ding Xu Breakdown of academic impact, for papers by Rebecca Johnson Breakdown of academic impact, for papers by Yangqian Shen
Rankless by CCL
2026